Ohtuvayre (Ensifentrine) - How to take Ensifentrine

Ohtuvayre (Ensifentrine) - Ensefentine is a novel inhaled bisphosphodiesterase inhibitor indicated to improve symptoms and reduce the frequency of disease exacerbations in adults with chronic obstructive pulmonary disease (COPD). This medication helps patients breathe better and improve their quality of life by opening up the airways and reducing inflammation within them. However, there are specific dosing regimens that need to be followed when using Ohtuvayre to ensure that it is safe and effective.

When usingOhtuvayre, patients must be aware that this medication is intended to be used with a nebulizer and is not intended to be used as an emergency treatment for sudden breathing problems. This means that if patients experience acute wheezing or difficulty breathing, they should seek immediate medical help and not rely on Ohtuvayre to relieve these emergencies. The recommended dose of Ohtuvayre is 3 mg twice daily in one unit dose ampoule, usually taken in the morning and evening. When patients use it, they need to use a standard jet atomizer to deliver the drug into the respiratory tract through oral inhalation.

In terms of medication management, patients should pay special attention to the usage details of Ohtuvayre unit dose ampoules First, before use, the ampoule should be removed from the aluminum foil packaging immediately and shake vigorously to ensure that the medicine is fully mixed. Next, squeeze out the contents of the ampoule and pour completely into the medicine cup of the nebulizer for oral inhalation through the nebulizer. During this process, any residual medication should be discarded to avoid affecting the effectiveness of the medication. Additionally, patients should ensure that the nebulizer they use has a mouthpiece and is connected to an air compressor to ensure smooth inhalation of the medication.

The drug compatibility of Ohtuvayre has not been established and therefore it should not be physically mixed with other drugs or added to solutions containing other drugs. This requirement is to avoid drug-drug interactions and ensure that the efficacy of Ohtuvayre is not affected. When using this drug, patients must strictly follow the doctor's advice and not arbitrarily change the dosage method or combine it with other drugs to ensure the safety of the treatment.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6433c98-41a0-4f99-8f7f-d0e9db6e3f40